[1,1'-Biphenyl]-2-yltrimethylsilane, 95%, 100mg

DBD-F [=4-(N,N-Dimethylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)100mg

4-Bromotetraphene, 95.0%, 10g

Boîtes de Pétri sans cames d'aération, Stériles 480 pcs

TERT-BUTYL 3-METHYL-4-OXOAZEPANE-1-CARBOXYLATE, 95.0%, 250mg

2-[(3-Aminopyridin-2-yl)methylene]hydrazinecarbothioamide>98.0%(HPLC)25mg

1-Bromo-4-butoxybenzene, 95.0%, 1g

ETHYL 7-BROMOIMIDAZO[1,5-A]PYRIDINE-1-CARBOXYLATE, 95.0%, 1g

(R)-1-Benzyl-N,N-dimethylpyrrolidin-3-amine, 95.0%, 250mg

H-Thr-OMe.HCl, 97%, 5g

2-hydroxy-3-(2-methoxyphenyl)prop-2-enoic acid, 95%, 500mg

(5-Chlorothiophen-3-yl)methanamine hydrochloride, 95.0%, 1g

2-(2-Bromoethyl)oxirane, 95.0%, 10g